Evidence map›Paper›PMID 36873122›Full record

Trial reportJournal of medicine and life2023

A randomised control trial on oral dydrogesterone

Joseph Ifeanyichukwu Ikechebelu, Cyril Chukwudi Dim, George Uchenna Eleje, Ngozi Joe-Ikechebelu, Boniface Chukwuneme Okpala, Princeston Chukwuemeka Okam

Open access · diamondAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of medicine and life, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Joseph Ifeanyichukwu IkechebeluDepartment of Obstetrics and Gynaecology, Faculty of Medicine, College of Health Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
Cyril Chukwudi DimInstitute of Maternal and Child Health, College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu, Nigeria.
George Uchenna ElejeDepartment of Obstetrics and Gynaecology, Faculty of Medicine, College of Health Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
Ngozi Joe-IkechebeluLife Fertility Centre, Life International Hospital, Awka, Nigeria.
Boniface Chukwuneme OkpalaDepartment of Obstetrics and Gynaecology, Faculty of Medicine, College of Health Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
Princeston Chukwuemeka OkamLife Fertility Centre, Life International Hospital, Awka, Nigeria.
University of Nigeria Teaching Hospital · NGNnamdi Azikiwe University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the pregnancy rates, adverse reactions, and medication costs of two luteal phase support regimens: oral dydrogesterone and micronized vaginal progesterone (MVP) pessary in

Indexed as

Abortion, SpontaneousDydrogesteroneFemaleFertilization in VitroHumansInfantLuteal PhasePessariesPregnancyProgesteroneDydrogesteroneProgesteronedydrogesteronein vitro fertilizationluteal-phase supportmicronized vaginal progesteronepessary

Identifiers

PMID36873122
PMCPMC9979184
OpenAlexW4323295441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.